Last reviewed · How we verify
NCT06753968
The Role of Natural Orifice Specimen Extraction Surgery (NOSES) in Treating Right-sided Colon Cancer
NA trial testing Laparoscopic Right Hemicolectomy With Transrectal/transvaginal Specimen Extraction (NOSES) in Colon Cancer in 349 participants. Completed in 1 August 2024.
1 January 2024
Quick facts
| Lead sponsor | National Cancer Center, China |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 349 |
| Start date | 1 January 2018 |
| Primary completion | 1 January 2024 |
| Estimated completion | 1 August 2024 |
| Sites | 1 location across China |
Drugs / interventions tested
- Laparoscopic Right Hemicolectomy With Transrectal/transvaginal Specimen Extraction (NOSES)
- Totally laparoscopic right hemicolectomy (TLRH)
Conditions studied
- Colon Cancer — all drugs for Colon Cancer →
Sponsor
National Cancer Center, China
Who can join
Adults 18 to 80, any sex, with Colon Cancer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to investigate the short-term and long-term outcomes between natural orifice specimen extraction surgery (NOSES) and totally laparoscopic right hemicolectomy (TLRH). The hypothesis is that NOSES could achieve good short-term and oncological outcomes for right colon cancer patients.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Comparative outcomes of natural orifice specimen extraction surgery versus totally laparoscopic surgery for right-sided colon cancer: a single-centre propensity score-matched study.
Xu Z, Zhang Y, Ma J, Gao C, et al · · 2026 · PMID 41822114 · DOI 10.3389/fsurg.2026.1716425
Verify or expand the search:
- PubMed search for NCT06753968
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Colon Cancer
Currently open trials in the same condition.
- NCT06923787 — Effect of Perioperative Intravenous Infusion of Lidocaine on the Postoperative Course and the Immune Response in Patient · Phase 2 · recruiting
- NCT07279077 — Node-Sparing Low-Dose Radiotherapy Concurrent With Chemotherapy and PD-1 Inhibitor in pMMR/MSS High-Risk Locally Advance · Phase 2 · recruiting
- NCT07205965 — The Effect of Acceptance and Commitment Approach-Based Psychoeducation in Cancer Survivors · NA · active not recruiting
- NCT07285356 — Study to Evaluate the Use of Surgical Gloves for the Prevention of Oxaliplatin-Induced Peripheral Neuropathy · NA · recruiting
- NCT07161713 — SBU-RESET: RElaxation, Stress Reduction and Epigenetics Trial in Cancer Survivors · NA · recruiting
Other National Cancer Center, China trials
Trials by the same sponsor.
- NCT07131345 — Study of Iparomlimab and Tuvonralimab Plus Chemotherapy in Malignant Mesothelioma · Phase 1, PHASE2 · not yet recruiting
- NCT06694129 — Real-world Observational Study of Targeted Therapy in Patients With Advanced ROS1-positive NSCLC · not yet recruiting
- NCT06414915 — Surufatinib Combined With Tislelizumab in Advanced Lung Cancer With Neuroendocrine Differentiation · Phase 2 · not yet recruiting
- NCT06362980 — A Study With BPI-1178 and Osimertinib in Advanced Non-small Cell Lung Cancer Patients With EGFR Mutations · Phase 1 · recruiting
- NCT06362902 — Laparoscopic Right Hemicolectomy With Transrectal Specimen Extraction for Colon Cancer · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06753968 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by National Cancer Center, China
- Last refreshed: 31 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06753968.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing